Inside Stayble: April 2021
In the April 2021 edition, CEO Andreas Gerward, discusses the ongoing clinical phase 2b, the recruitment of Sara Richardson in the newly created role VP CMC & Regulatory Affairs and partnering activities.
Inside Stayble is a communication channel aiming to provide shareholders with monthly updates about Stayble Therapeutics and its clinical development program for STA363 in chronic low back pain.
Stayble Therapeutics is listed on Nasdaq First North in Sweden (STABL).
Read more at staybletherapeutics.com